Back
Integra Lifesciences Holdings Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
40
IART
Integra Lifesciences Holdings
Last Price:
24.38
Seasonality Move:
15.38%
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
137.02
Seasonality Move:
14.88%
Sell
40
Integra Lifesciences Holdings (IART)
is a Sell
Is Integra Lifesciences Holdings a Buy, Sell or Hold?
- The current Integra Lifesciences Holdings [IART] share price is $23.70. The Score for IART is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- IART is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IART Stock Price Chart
What is Integra Lifesciences Holdings's stock price today?
-
The Integra Lifesciences Holdings share price today is $23.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IART is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
IART Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.87 | Buy |
Relative Strength Index (14 RSI): | 58.23 | Buy |
Chaikin Money Flow: | -135541 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.01 - 24.93) | Buy |
Bollinger Bands (100): | (17.68 - 26.46) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.3 | Sell |
Relative Strength Index (14 RSI): | 64.59 | Buy |
Chaikin Money Flow: | 3149400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.02 - 128.88) | Buy |
Bollinger Bands (100): | (119.18 - 142.3) | Sell |
IART Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.21 | Buy |
20-day SMA: | 23.3 | Buy |
50-day SMA: | 20.3 | Buy |
200-day SMA: | 27.29 | Sell |
8-day EMA: | 23.51 | Buy |
20-day EMA: | 22.87 | Buy |
50-day EMA: | 21.78 | Buy |
200-day EMA: | 26.8 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.07 | Buy |
20-day SMA: | 117.27 | Buy |
50-day SMA: | 121.92 | Buy |
200-day SMA: | 129.99 | Buy |
8-day EMA: | 116.28 | Buy |
20-day EMA: | 117.14 | Buy |
50-day EMA: | 121.91 | Buy |
200-day EMA: | 125.98 | Buy |
Integra Lifesciences Holdings Earnings Growth & IART Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $0.06 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.
Integra Lifesciences Holdings Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |